Literature DB >> 26970121

Introduction: Cancer chemoprevention and its context.

Barbara K Dunn1, Asad Umar2, Ellen Richmond2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26970121      PMCID: PMC5166611          DOI: 10.1053/j.seminoncol.2015.11.002

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  25 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Tumor heterogeneity and personalized medicine.

Authors:  Dan L Longo
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

Review 3.  Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer.

Authors:  Cindy D Davis; Nancy J Emenaker; John A Milner
Journal:  Semin Oncol       Date:  2010-06       Impact factor: 4.929

4.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

5.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

Review 6.  Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

Authors:  Gary J Kelloff; Scott M Lippman; Andrew J Dannenberg; Caroline C Sigman; Homer L Pearce; Brian J Reid; Eva Szabo; V Craig Jordan; Margaret R Spitz; Gordon B Mills; Vali A Papadimitrakopoulou; Reuben Lotan; Bharat B Aggarwal; Robert S Bresalier; Jeri Kim; Banu Arun; Karen H Lu; Melanie E Thomas; Helen E Rhodes; Molly A Brewer; Michele Follen; Dong M Shin; Howard L Parnes; Jill M Siegfried; Alison A Evans; William J Blot; Wong-Ho Chow; Patricia L Blount; Carlo C Maley; Kenneth K Wang; Stephen Lam; J Jack Lee; Steven M Dubinett; Paul F Engstrom; Frank L Meyskens; Joyce O'Shaughnessy; Ernest T Hawk; Bernard Levin; William G Nelson; Waun Ki Hong
Journal:  Clin Cancer Res       Date:  2006-06-15       Impact factor: 12.531

Review 7.  Cancer prevention with natural compounds.

Authors:  Norleena P Gullett; A R M Ruhul Amin; Soley Bayraktar; John M Pezzuto; Dong M Shin; Fadlo R Khuri; Bharat B Aggarwal; Young-Joon Surh; Omer Kucuk
Journal:  Semin Oncol       Date:  2010-06       Impact factor: 4.929

8.  Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-19

Review 9.  Rationale and strategies for chemoprevention of cancer in humans.

Authors:  J S Bertram; L N Kolonel; F L Meyskens
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

Review 10.  Molecular profiling and the reclassification of cancer: divide and conquer.

Authors:  Javier Munoz; Charles Swanton; Razelle Kurzrock
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013
View more
  4 in total

1.  Drugs for preventing lung cancer in healthy people.

Authors:  Marcela Cortés-Jofré; José-Ramón Rueda; Claudia Asenjo-Lobos; Eva Madrid; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

Review 2.  Chemopreventive Agents in Oral Premalignancy: A Medical Management Review.

Authors:  Chintada Suvarna; Nallan Csk Chaitanya; Shaik Ameer; Pavitra Inamdar; Swetha Alugubelli; Alakananda Bhagyanagar
Journal:  J Int Soc Prev Community Dent       Date:  2020-04-02

3.  In Vitro and In Vivo Anticancer Activity of the Most Cytotoxic Fraction of Pistachio Hull Extract in Breast Cancer.

Authors:  Maryam Seifaddinipour; Reyhaneh Farghadani; Farideh Namvar; Jamaludin Bin Mohamad; Nur Airina Muhamad
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

Review 4.  Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathways.

Authors:  Peter Kubatka; Alena Mazurakova; Marek Samec; Lenka Koklesova; Kevin Zhai; Raghad Al-Ishaq; Karol Kajo; Kamil Biringer; Desanka Vybohova; Aranka Brockmueller; Martin Pec; Mehdi Shakibaei; Frank A Giordano; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  EPMA J       Date:  2021-10-06       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.